日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia

t(14;16)(q32;q24)导致的FOXF1/FENDRR基因失调定义了一种高危谱系模糊白血病亚型。

Di Giacomo, Danika; Pölönen, Petri; Bardelli, Valentina; Kimura, Shunsuke; Pierini, Valentina; Pagliaro, Luca; Arniani, Silvia; Chang, Yunchao; Gao, Qingsong; Montefiori, Lindsey E; Wu, Yiming; Park, Chun Shik; Wright, William C; Vento, Federica; Wei, Huimei; Matteucci, Caterina; Lei, Shaohua; Rosikiewicz, Wojciech; Nardelli, Carlotta; Lema Fernandez, Anair Graciela; Østergaard, Anna; Backhaus, Emily A; Baviskar, Pradyumna; Cerrano, Marco; Leoncin, Matteo; Manabe, Atsushi; Hirabayashi, Shinsuke; Takita, Junko; Hasegawa, Daisuke; Miyamoto, Satoshi; Macchiarulo, Antonio; Xu, Jason; Teachey, David Trent; Roti, Giovanni; Iacobucci, Ilaria; La Starza, Roberta; Mecucci, Cristina; Mullighan, Charles G

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V(H)1-2-rearranging mouse models.

在不同的单人类 V(H)1-2 重排小鼠模型中,复发性 SARS-CoV-2 Omicron 广谱中和人源化抗体。

Batra Himanshu, Luo Sai, Saunders Kevin O, Higgins Jaclyn S, Jian Fanchong, Zhang Jun, Kibria Md Golam, Jonaid G M, Zhou Qingchen J, Eaton Amanda, Cronin Kenneth, Mallory Michael L, Mattocks Melissa, Edwards Robert J, Parks Robert, Lee Esther M, Ye Adam Yongxin, Williams Aimee Chapdelaine, Jung Geeyoun, Mansouri Katayoun, Alam S Munir, Montefiori David C, Tian Ming, Baric Ralph S, Cao Yunlong, Haynes Barton F, Chen Bing, Alt Frederick W

HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines

HIV膜近端外部区域支架免疫原作为灭活全细胞基因组减少疫苗

Quintero-Barbosa, Juan Sebastian; Song, Yufeng; Mehl, Frances; Mathur, Shubham; Livingston, Lauren; Kwong, Peter D; Shen, Xiaoying; Montefiori, David C; Zeichner, Steven L

Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques.

感染 HIV 的恒河猴体内遗传多样性 B 细胞受体的功能趋同性。

Song Shengli, Li Hui, Yeh Chen-Hao, Watanabe Akiko, Kuraoka Masayuki, Gao Hongmei, Shen Xiaoying, LaBranche Celia C, Williams Wilton B, Saunders Kevin O, Moody M Anthony, Wiehe Kevin, Montefiori David C, Haynes Barton F, Shaw George M, Kelsoe Garnett

Precise targeting of HIV broadly neutralizing antibody precursors in humans

精准靶向人类体内HIV广谱中和抗体前体

Tom G Caniels #,Madhu Prabhakaran #,Gabriel Ozorowski,Kellie J MacPhee,Weiwei Wu,Karlijn van der Straten,Sashank Agrawal,Ronald Derking,Emma I M M Reiss,Katrina Millard,Martina Turroja,Aimee Desrosiers,Jeffrey Bethony,Elissa Malkin,Marinus H Liesdek,Annelou van der Veen,Michelle Klouwens,Jonne L Snitselaar,Joey H Bouhuijs,Rhianna Bronson,Jalen Jean-Baptiste,Suprabhath Gajjala,Zahra Rikhtegaran Tehrani,Alison Benner,Mukundhan Ramaswami,Michael O Duff,Yung-Wen Liu,Alicia H Sato,Ju Yeong Kim,Isabel J L Baken,Catarina Mendes Silva,Tom P L Bijl,Jacqueline van Rijswijk,Judith A Burger,Albert Cupo,Anila Yasmeen,Swastik Phulera,Wen-Hsin Lee,Kipchoge N Randall Jr,Shiyu Zhang,Martin M Corcoran,Isabel Regadas,Alex C Sullivan,David M Brown,Jennifer A Bohl,Kelli M Greene,Hongmei Gao,Nicole L Yates,Sheetal Sawant,Jan M Prins,Neeltje A Kootstra,Stephen M Kaminsky,Burc Barin,Farhad Rahaman,Margaret Meller,Vince Philiponis,Dagna S Laufer,Angela Lombardo,Lindsey Mwoga,Solmaz Shotorbani,Drienna Holman,Richard A Koup,Per Johan Klasse,Gunilla B Karlsson Hedestam,Georgia D Tomaras,Marit J van Gils,David C Montefiori,Adrian B McDermott,Ollivier Hyrien,John P Moore,Ian A Wilson,Andrew B Ward,David J Diemert,Godelieve J de Bree,Sarah F Andrews,Marina Caskey,Rogier W Sanders

Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia

Venetoclax联合gilteritinib在FLT3突变型BCL11B-a谱系不明确白血病的临床前模型中有效。

Lindsey E Montefiori,Ilaria Iacobucci,Qingsong Gao,Jamila Moore,William C Wright,Huimei Wei,Pradyumna Baviskar,Surbhi Sona,Hongjian Jin,Amit Budhraja,Josi Lott,Qi Zhang Tatarata,Zhongshan Cheng,Tanya Khan,Emily A Backhaus Wagner,Melissa Johnson,Cyrus M Mehr,Burgess Freeman,Laura Janke,Torsten Haferlach,Paul Geeleher,Paul E Mead,Marina Konopleva,Joseph T Opferman,Charles G Mullighan

HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques

采用ALFQA佐剂配制的HIV候选疫苗ΔV1gp120可增强雌性猕猴的黏膜免疫力

Massimiliano Bissa #,Mohammad Arif Rahman #,Luca Schifanella #,Katherine C Goldfarbmuren #,Isabela Silva de Castro #,Emmanuel K Woode,Anna Gutowska,Melvin N Doster,Sophia Brown,Sarkis Sarkis,Neil R Kanchetty,Cynthia A Pise-Masison,Robyn Washington-Parks,Katherine McKinnon,Shraddha Basu,Jiae Kim,Ryan Alving,Dominic Paquin-Proulx,Kombo F N'guessan,Xiaoying Shen,David C Montefiori,Timothy Cardozo,Gary R Matyas,Mangala Rao,Genoveffa Franchini

HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques

采用ALFQA佐剂配制的HIV候选疫苗ΔV1gp120可增强雌性猕猴的黏膜免疫力

Massimiliano Bissa # ,Mohammad Arif Rahman # ,Luca Schifanella # ,Katherine C Goldfarbmuren # ,Isabela Silva de Castro # ,Emmanuel K Woode ,Anna Gutowska ,Melvin N Doster ,Sophia Brown ,Sarkis Sarkis ,Neil R Kanchetty ,Cynthia A Pise-Masison ,Robyn Washington-Parks ,Katherine McKinnon ,Shraddha Basu ,Jiae Kim ,Ryan Alving ,Dominic Paquin-Proulx ,Kombo F N'guessan ,Xiaoying Shen ,David C Montefiori ,Timothy Cardozo ,Gary R Matyas ,Mangala Rao ,Genoveffa Franchini

Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.

非稳定型 SARS-CoV-2 刺突 mRNA 疫苗可在非人灵长类动物中诱导产生广谱中和抗体。

Malewana R Dilshan, Stalls Victoria, May Aaron, Lu Xiaozhi, Martinez David R, Schäfer Alexandra, Li Dapeng, Barr Maggie, Sutherland Laura L, Lee Esther, Parks Robert, Beck Whitney Edwards, Newman Amanda, Bock Kevin W, Minai Mahnaz, Nagata Bianca M, DeMarco C Todd, Denny Thomas N, Oguin Thomas H 3rd, Rountree Wes, Wang Yunfei, Mansouri Katayoun, Edwards Robert J, Smith Lena, Sempowski Gregory D, Eaton Amanda, Muramatsu Hiromi, Henderson Rory, Tam Ying, Barbosa Christopher, Tang Juanjie, Cain Derek W, Santra Sampa, Moore Ian N, Andersen Hanne, Lewis Mark G, Golding Hana, Seder Robert, Khurana Surender, Montefiori David C, Pardi Norbert, Weissman Drew, Baric Ralph S, Acharya Priyamvada, Haynes Barton F, Saunders Kevin O

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

在美国,一项首次人体I期随机试验,旨在评估V2特异性HIV-1广谱中和抗体PGDM1400LS在未感染HIV-1的人群中静脉或皮下输注的安全性、药代动力学和中和活性(HVTN 140/HPTN 101 A部分):一项首次人体试验。

Seaton, Kelly E; Paez, Carmen A; Yu, Chenchen; Karuna, Shelly T; Gamble, Theresa; Miner, Maurine D; Heptinstall, Jack; Zhang, Lu; Gao, Fei; Yacovone, Margaret; Spiegel, Hans; Dumond, Julie B; Anderson, Maija; Piwowar-Manning, Estelle; Dye, Bonnie; Tindale, India; Proulx-Burns, Lori; Trahey, Meg; Takuva, Simbarashe; Takalani, Azwidihwi; Bailey, Veronique C; Kalams, Spyros A; Scott, Hyman; Mkhize, Nonhlanhla N; Weiner, Joshua A; Ackerman, Margaret E; McElrath, M Juliana; Pensiero, Michael; Barouch, Dan H; Montefiori, David; Tomaras, Georgia D; Corey, Lawrence; Cohen, Myron S; Huang, Yunda; Mahomed, Sharana; Siegel, Marc; Kelley, Colleen F